Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity
Open accessThe DOI matches its Crossref record; 239 of the 241 references it cites were found in a registry or an index.
Abstract
Cancer cell heterogeneity is a key contributor to therapeutic failure and post-treatment recurrence. Targeting cell subpopulations responsible for chemoresistance and recurrence seems to be an attractive approach to improve treatment outcome in cancer patients. However, this remains challenging due to the complexity and incomplete characterization of tumor cell subpopulations. The heterogeneity of cells exhibiting stemness-related features, such as self-renewal and chemoresistance, fuels this complexity. Notch signaling is a known regulator of cancer stem cell (CSC) features in colorectal cancer (CRC), though the effects of its heterogenous signaling on CRC cell stemness are only just emerging. In this review, we discuss how Notch ligand-receptor specificity contributes to regulating stemness, self-renewal, chemoresistance and cancer stem cells heterogeneity in CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The Notch signaling pathway plays a significant role in CSC self-renewal and cell fate decisions, and dysregulated Notch signaling contributes to CRC progression, chemoresistance, and CSC heterogeneity [196].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [196]
The cited source says what the claim attributes to it.
In the citing paper
“Neutralizing mAbs targeting Notch receptors or ligands, such as delta ligand-4 (DLL4), have also been developed to block Notch signaling and were reported to reduce colorectal CSC self-renewal and tumor growth in vivo [196].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [196]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Brenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
Rawla, P., Sunkara, T., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.81072 · Cited by 2,323
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Douillard, J.-Y., Oliner, K. S., Siena, S., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305275 · Cited by 2,263
Evolution of the Cancer Stem Cell Model
Kreso, A., & Dick, J. E. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,224
Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life
Morrison, S. J., & Spradling, A. C. (2008) · Cell · doi:10.1016/j.cell.2008.01.038 · Cited by 1,955
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Arain, M. A., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Farkas, L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0012 · Cited by 1,696
van Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Labianca, R., Nordlinger, B., Beretta, G. D., Mosconi, S., Mandalà, M., Cervantes, A., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt354 · Cited by 1,404
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., & Vogelstein, B. (1990) · PubMed · Cited by 1,260
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Shackleton, M., Quintana, E., Fearon, E. R., & Morrison, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.08.017 · Cited by 1,162
The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
Benedito, R., Roca, C., Sörensen, I., Adams, S., Gossler, A., Fruttiger, M., & Adams, R. H. (2009) · Cell · doi:10.1016/j.cell.2009.03.025 · Cited by 1,107
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Magee, J. A., Piskounova, E., & Morrison, S. J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.003 · Cited by 1,101
Duration of adjuvant chemotherapy for stage III colon cancer
Grothey, A., Sobrero, A. F., Shields, A. F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713709 · Cited by 1,092
Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium
El Marjou, F., Janssen, K., Hung‐Junn Chang, B., Li, M., Hindie, V., Chan, L., Louvard, D., Chambon, P., Metzger, D., & Robine, S. (2004) · genesis · doi:10.1002/gene.20042 · Cited by 1,060
AJCC 8th Edition: Colorectal Cancer
Weiser, M. R. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6462-1 · Cited by 1,020 · cited 1×
“Recurrence patterns may involve local, regional, or distant metastasis (Weiser, 2018).”
BackgroundTrujillo, C. A., Gao, R., Negraes, P. D., Gu, J., Buchanan, J., Preissl, S., Wang, A., Wu, W., Haddad, G. G., Chaim, I. A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.08.002 · Cited by 974
Notch signals control the fate of immature progenitor cells in the intestine
Fre, S., Huyghe, M., Mourikis, P., Robine, S., Louvard, D., & Artavanis-Tsakonas, S. (2005) · Nature · doi:10.1038/nature03589 · Cited by 935
Shmelkov, S. V., Butler, J. M., Hooper, A. T., Hormigo, A., Kushner, J., Milde, T., St. Clair, R., Baljevic, M., White, I., Jin, D. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34401 · Cited by 896
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
Oskarsson, T., Acharyya, S., Zhang, X. H.-F., Vanharanta, S., Tavazoie, S. F., Morris, P. G., Downey, R. J., Manova-Todorova, K., Brogi, E., & Massagué, J. (2011) · Nature Medicine · doi:10.1038/nm.2379 · Cited by 869
Fringe is a glycosyltransferase that modifies Notch
Moloney, D. J., Panin, V. M., Johnston, S. H., Chen, J., Shao, L., Wilson, R., Wang, Y., Stanley, P., Irvine, K. D., Haltiwanger, R. S., et al. (2000) · Nature · doi:10.1038/35019000 · Cited by 852
Palomero, T., Lim, W. K., Odom, D. T., Sulis, M. L., Real, P. J., Margolin, A., Barnes, K. C., O'Neil, J., Neuberg, D., Weng, A. P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606108103 · Cited by 826
Intra-tumor heterogeneity from a cancer stem cell perspective
Prasetyanti, P. R., & Medema, J. P. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0600-4 · Cited by 800
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum
Kambara, T., Simms, L. A., Whitehall, V. L. J., Spring, K. J., Wynter, C. V. A., Walsh, M. D., Barker, M. A., Arnold, S., McGivern, A., Matsubara, N., et al. (2004) · Gut · doi:10.1136/gut.2003.037671 · Cited by 722
Mechanisms of chemoresistance in cancer stem cells
Abdullah, L. N., & Chow, E. K. (2013) · Clinical and Translational Medicine · doi:10.1186/2001-1326-2-3 · Cited by 721
Oscillations in Notch Signaling Regulate Maintenance of Neural Progenitors
Shimojo, H., Ohtsuka, T., & Kageyama, R. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.014 · Cited by 706
The Notch signalling system: recent insights into the complexity of a conserved pathway
Guruharsha, K. G., Kankel, M. W., & Artavanis-Tsakonas, S. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3272 · Cited by 705
The Hes gene family: repressors and oscillators that orchestrate embryogenesis
Kageyama, R., Ohtsuka, T., & Kobayashi, T. (2007) · Development · doi:10.1242/dev.000786 · Cited by 644
Pathways of Colorectal Carcinogenesis
Nguyen, L. H., Goel, A., & Chung, D. C. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.08.059 · Cited by 606 · cited 1×
“In contrast, traditional serrated adenomas usually display low methylation, a stable microsatellite pro fi le (MSS), may exhibit mutations in KRAS or BRAF, but are mostly characterized by their high level of TGF β pathway activation (Nguyen et al., 2020; Kim and Bodmer, 2022) (Figure 1).”
BackgroundAldehyde dehydrogenase 1A1 in stem cells and cancer
Tomita, H., Tanaka, K., Tanaka, T., & Hara, A. (2016) · Oncotarget · doi:10.18632/oncotarget.6920 · Cited by 595
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
Ramirez, M., Rajaram, S., Steininger, R. J., Osipchuk, D., Roth, M. A., Morinishi, L. S., Evans, L., Ji, W., Hsu, C.-H., Thurley, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms10690 · Cited by 581
Understanding cancer stem cell heterogeneity and plasticity
Tang, D. G. (2012) · Cell Research · doi:10.1038/cr.2012.13 · Cited by 563
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Liau, B. B., Sievers, C., Donohue, L. K., Gillespie, S. M., Flavahan, W. A., Miller, T. E., Venteicher, A. S., Hebert, C. H., Carey, C. D., Rodig, S. J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2016.11.003 · Cited by 535
Metastatic Colorectal Cancer: Current State and Future Directions
Fakih, M. G. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7633 · Cited by 527
Cancer stem cell niche: the place to be
Borovski, T., De Sousa E Melo, F., Vermeulen, L., & Medema, J. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3220 · Cited by 518
Blondy, S., David, V., Verdier, M., Mathonnet, M., Perraud, A., & Christou, N. (2020) · Cancer Science · doi:10.1111/cas.14532 · Cited by 507
Molecular determinants of dysplasia in colorectal lesions.
Jen, J., Powell, S. M., Papadopoulos, N., Smith, K. J., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1994) · PubMed · Cited by 504
Cellular Heterogeneity and Molecular Evolution in Cancer
Almendro, V., Marusyk, A., & Polyak, K. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163923 · Cited by 498
Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy
Rehman, S. K., Haynes, J., Collignon, E., Brown, K. R., Wang, Y., Nixon, A. M. L., Bruce, J. P., Wintersinger, J. A., Singh Mer, A., Lo, E. B. L., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.018 · Cited by 495
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
Lim, J. S., Ibaseta, A., Fischer, M. M., Cancilla, B., O’Young, G., Cristea, S., Luca, V. C., Yang, D., Jahchan, N. S., Hamard, C., et al. (2017) · Nature · doi:10.1038/nature22323 · Cited by 485
Screening cell–cell communication in spatial transcriptomics via collective optimal transport
(2023) · doi:10.1038/s41592-022-01728-4 · Cited by 484
Cancer Stem Cells and Drug Resistance: The Potential of Nanomedicine
Vinogradov, S., & Wei, X. (2012) · Nanomedicine · doi:10.2217/nnm.12.22 · Cited by 474
Lu, J., Ye, X., Fan, F., Xia, L., Bhattacharya, R., Bellister, S., Tozzi, F., Sceusi, E., Zhou, Y., Tachibana, I., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.021 · Cited by 447
The molecular basis of endothelial cell plasticity
Dejana, E., Hirschi, K. K., & Simons, M. (2017) · Nature Communications · doi:10.1038/ncomms14361 · Cited by 441
Jackstadt, R., van Hooff, S. R., Leach, J. D., Cortes-Lavaud, X., Lohuis, J. O., Ridgway, R. A., Wouters, V. M., Roper, J., Kendall, T. J., Roxburgh, C. S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.003 · Cited by 433
Dll1- and Dll4-Mediated Notch Signaling Are Required for Homeostasis of Intestinal Stem Cells
Pellegrinet, L., Rodilla, V., Liu, Z., Chen, S., Koch, U., Espinosa, L., Kaestner, K. H., Kopan, R., Lewis, J., & Radtke, F. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.005 · Cited by 431
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Takebe, N., Nguyen, D., & Yang, S. X. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.005 · Cited by 413
Riccio, O., van Gijn, M. E., Bezdek, A. C., Pellegrinet, L., van Es, J. H., Zimber‐Strobl, U., Strobl, L. J., Honjo, T., Clevers, H., & Radtke, F. (2008) · EMBO reports · doi:10.1038/embor.2008.7 · Cited by 410
Notch signaling: An emerging therapeutic target for cancer treatment
Yuan, X., Wu, H., Xu, H., Xiong, H., Chu, Q., Yu, S., Wu, G. S., & Wu, K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.048 · Cited by 402
Fischer, A., & Gessler, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm477 · Cited by 400
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Hoey, T., Yen, W.-C., Axelrod, F., Basi, J., Donigian, L., Dylla, S., Fitch-Bruhns, M., Lazetic, S., Park, I.-K., Sato, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.019 · Cited by 398
Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer
Rodilla, V., Villanueva, A., Obrador-Hevia, A., Robert-Moreno, À., Fernández-Majada, V., Grilli, A., López-Bigas, N., Bellora, N., Albà, M. M., Torres, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813221106 · Cited by 384
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Ntziachristos, P., Lim, J. S., Sage, J., & Aifantis, I. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.018 · Cited by 374
Colorectal Cancer Stem Cells: From the Crypt to the Clinic
Zeuner, A., Todaro, M., Stassi, G., & De Maria, R. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.012 · Cited by 368
Function of RNA-binding protein Musashi-1 in stem cells
Okano, H., Kawahara, H., Toriya, M., Nakao, K., Shibata, S., & Imai, T. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.02.021 · Cited by 365
Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice
Bellavia, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3337 · Cited by 362
A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
Bu, P., Chen, K.-Y., Chen, J. H., Wang, L., Walters, J., Shin, Y. J., Goerger, J. P., Sun, J., Witherspoon, M., Rakhilin, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.002 · Cited by 357
Targeting Cancer Cell Dormancy
Recasens, A., & Munoz, L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.12.004 · Cited by 356 · cited 1×
“Although these DTP-cells revert to a chemo sensitive state after treatment withdrawal (Recasens and Munoz, 2019), tumors in a DTP state may act as a transient reservoir for the development of genetically resistant clones (Ramirez et al., 2016), demonstrating the importance of non-genetic…”
BackgroundTumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
Zhang, A., Miao, K., Sun, H., & Deng, C.-X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72534 · Cited by 352
Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine
Fre, S., Pallavi, S. K., Huyghe, M., Laé, M., Janssen, K.-P., Robine, S., Artavanis-Tsakonas, S., & Louvard, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900427106 · Cited by 345
The Role of the Extracellular Matrix in Cancer Stemness
Nallanthighal, S., Heiserman, J. P., & Cheon, D.-J. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00086 · Cited by 344
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
Martinez-Balibrea, E., Martínez-Cardús, A., Ginés, A., Ruiz de Porras, V., Moutinho, C., Layos, L., Manzano, J. L., Bugés, C., Bystrup, S., Esteller, M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0636 · Cited by 335
Touil, Y., Igoudjil, W., Corvaisier, M., Dessein, A.-F., Vandomme, J., Monté, D., Stechly, L., Skrypek, N., Langlois, C., Grard, G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1854 · Cited by 332
Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
Fujita, K.-I. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12234 · Cited by 323
Dynamic Ligand Discrimination in the Notch Signaling Pathway
Nandagopal, N., Santat, L. A., LeBon, L., Sprinzak, D., Bronner, M. E., & Elowitz, M. B. (2018) · Cell · doi:10.1016/j.cell.2018.01.002 · Cited by 322
Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer
Fumagalli, A., Oost, K. C., Kester, L., Morgner, J., Bornes, L., Bruens, L., Spaargaren, L., Azkanaz, M., Schelfhorst, T., Beerling, E., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.02.008 · Cited by 319
An activated Notch receptor blocks cell-fate commitment in the developing Drosophila eye
Fortini, M. E., Rebay, I., Caron, L. A., & Artavanis-Tsakonas, S. (1993) · Nature · doi:10.1038/365555a0 · Cited by 301
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
Bocci, F., Gearhart-Serna, L., Boareto, M., Ribeiro, M., Ben-Jacob, E., Devi, G. R., Levine, H., Onuchic, J. N., & Jolly, M. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815345116 · Cited by 299
Cancer stem cells in progression of colorectal cancer
Zhou, Y., Xia, L., Wang, H., Oyang, L., Su, M., Liu, Q., Lin, J., Tan, S., Tian, Y., Liao, Q., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.23607 · Cited by 298
tRF/miR-1280 Suppresses Stem Cell–like Cells and Metastasis in Colorectal Cancer
Huang, B., Yang, H., Cheng, X., Wang, D., Fu, S., Shen, W., Zhang, Q., Zhang, L., Xue, Z., Li, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3146 · Cited by 295
Sikandar, S. S., Pate, K. T., Anderson, S., Dizon, D., Edwards, R. A., Waterman, M. L., & Lipkin, S. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2557 · Cited by 288
Meng, R. D., Shelton, C. C., Li, Y.-M., Qin, L.-X., Notterman, D., Paty, P. B., & Schwartz, G. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2088 · Cited by 287
Yang, S., Farraye, F. A., Mack, C., Posnik, O., & O’Brien, M. J. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000141404.56839.6a · Cited by 286
Kayahara, T., Sawada, M., Takaishi, S., Fukui, H., Seno, H., Fukuzawa, H., Suzuki, K., Hiai, H., Kageyama, R., Okano, H., et al. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03896-6 · Cited by 285
Inhibition of mTOR induces a paused pluripotent state
Bulut-Karslioglu, A., Biechele, S., Jin, H., Macrae, T. A., Hejna, M., Gertsenstein, M., Song, J. S., & Ramalho-Santos, M. (2016) · Nature · doi:10.1038/nature20578 · Cited by 283
Mechanism and Significance of cis-Inhibition in Notch Signalling
del Álamo, D., Rouault, H., & Schweisguth, F. (2011) · Current Biology · doi:10.1016/j.cub.2010.10.034 · Cited by 262
Regulation of the Pancreatic Pro-Endocrine Gene Neurogenin3
Lee, J. C., Smith, S. B., Watada, H., Lin, J., Scheel, D., Wang, J., Mirmira, R. G., & German, M. S. (2001) · Diabetes · doi:10.2337/diabetes.50.5.928 · Cited by 257
Sveen, A., Bruun, J., Eide, P. W., Eilertsen, I. A., Ramirez, L., Murumägi, A., Arjama, M., Danielsen, S. A., Kryeziu, K., Elez, E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1234 · Cited by 256
THE ADENOMATOUS POLYPOSIS COLI PROTEIN: The Achilles Heel of the Gut Epithelium
Näthke, I. S. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.094541 · Cited by 254
ATM, a central controller of cellular responses to DNA damage
Khanna, K., Lavin, M., Jackson, S., & Mulhern, T. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400874 · Cited by 252
ABC Transporter-Mediated Multidrug-Resistant Cancer
Amawi, H., Sim, H.-M., Tiwari, A. K., Ambudkar, S. V., & Shukla, S. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-7647-4_12 · Cited by 228
Overview on Clinical Relevance of Intra-Tumor Heterogeneity
Stanta, G., & Bonin, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00085 · Cited by 224
HERP, a Novel Heterodimer Partner of HES/E(spl) in Notch Signaling
Iso, T., Sartorelli, V., Poizat, C., Iezzi, S., Wu, H.-Y., Chung, G., Kedes, L., & Hamamori, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.6080-6089.2001 · Cited by 217
The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment
Ye, J., Wu, D., Wu, P., Chen, Z., & Huang, J. (2014) · Tumor Biology · doi:10.1007/s13277-013-1561-x · Cited by 216
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
De Angelis, M. L., Francescangeli, F., La Torre, F., & Zeuner, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00626 · Cited by 206
Activation of Notch signaling in human colon adenocarcinoma
Egan (1992) · International Journal of Oncology · doi:10.3892/ijo_00000112 · Cited by 206
Vellinga, T. T., Borovski, T., de Boer, V. C. J., Fatrai, S., van Schelven, S., Trumpi, K., Verheem, A., Snoeren, N., Emmink, B. L., Koster, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2290 · Cited by 203
Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche
Chakrabarti, R., Celià-Terrassa, T., Kumar, S., Hang, X., Wei, Y., Choudhury, A., Hwang, J., Peng, J., Nixon, B., Grady, J. J., et al. (2018) · Science · doi:10.1126/science.aan4153 · Cited by 195
Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications.
Thanki, K. K., Nicholls, M. E., Gajjar, A. H., Senagore, A. J., Qiu, S., Szabó, C., Hellmich, M. R., & Chao, C. (2017) · PubMed · Cited by 195
Robustness, Flexibility, and the Role of Lateral Inhibition in the Neurogenic Network
Meir, E., von Dassow, G., Munro, E., & Odell, G. M. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00839-4 · Cited by 194
Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer
Cabanos, H. F., & Hata, A. N. (2021) · Cancers · doi:10.3390/cancers13112666 · Cited by 189 · cited 1×
“By doing so, DTP cells display resistance to a wide variety of chemotherapeutic agents (De Angelis et al., 2019), radiotherapy (Zhao Y. et al., 2020), and targeted therapies (Cabanos and Hata, 2021).”
BackgroundDiscovery of the cancer stem cell related determinants of radioresistance
Peitzsch, C., Kurth, I., Kunz-Schughart, L., Baumann, M., & Dubrovska, A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.003 · Cited by 189
A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability
Morel, A.-P., Ginestier, C., Pommier, R. M., Cabaud, O., Ruiz, E., Wicinski, J., Devouassoux-Shisheboran, M., Combaret, V., Finetti, P., Chassot, C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4323 · Cited by 186
Self-citationBeatus, P., Lundkvist, J., Öberg, C., & Lendahl*, U. (1999) · Development · doi:10.1242/dev.126.17.3925 · Cited by 185
Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
Miele, L., Espinoza, I., Pochampally, Watabe, & Xing, F. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36162 · Cited by 183
A Review on Notch Signaling and Colorectal Cancer
Tyagi, A., Sharma, A. K., & Damodaran, C. (2020) · Cells · doi:10.3390/cells9061549 · Cited by 179
The Notch pathway in colorectal cancer
Vinson, K. E., George, D. C., Fender, A. W., Bertrand, F. E., & Sigounas, G. (2016) · International Journal of Cancer · doi:10.1002/ijc.29800 · Cited by 175
Cell adhesion molecules and their relation to (cancer) cell stemness
Farahani, E., Patra, H. K., Jangamreddy, J. R., Rashedi, I., Kawalec, M., Rao Pariti, R. K., Batakis, P., & Wiechec, E. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu045 · Cited by 174
Rosenberg, D. W., Yang, S., Pleau, D. C., Greenspan, E. J., Stevens, R. G., Rajan, T. V., Heinen, C. D., Levine, J., Zhou, Y., & O'Brien, M. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0343 · Cited by 171
Notch signal strength controls cell fate in the haemogenic endothelium
Gama-Norton, L., Ferrando, E., Ruiz-Herguido, C., Liu, Z., Guiu, J., Islam, A. B. M. M. K., Lee, S.-U., Yan, M., Guidos, C. J., López-Bigas, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9510 · Cited by 171
Lenos, K. J., Miedema, D. M., Lodestijn, S. C., Nijman, L. E., van den Bosch, T., Romero Ros, X., Lourenço, F. C., Lecca, M. C., van der Heijden, M., van Neerven, S. M., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0179-z · Cited by 168
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy
Álvarez-Varela, A., Novellasdemunt, L., Barriga, F. M., Hernando‐Momblona, X., Cañellas-Socias, A., Cano-Crespo, S., Sevillano, M., Cortina, C., Stork, D., Morral, C., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00402-0 · Cited by 164
Leimeister, C., Dale, K., Fischer, A., Klamt, B., Hrabe de Angelis, M., Radtke, F., McGrew, M. J., Pourquié, O., & Gessler, M. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9884 · Cited by 164
Denise, C., Paoli, P., Calvani, M., Taddei, M. L., Giannoni, E., Kopetz, S., Kazmi, S. M. A., Pia, M. M., Pettazzoni, P., Sacco, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5991 · Cited by 164
Notch regulation of gastrointestinal stem cells
Demitrack, E. S., & Samuelson, L. C. (2016) · The Journal of Physiology · doi:10.1113/jp271667 · Cited by 164
Notch‐1 Promotes Stemness and Epithelial to Mesenchymal Transition in Colorectal Cancer
Fender, A. W., Nutter, J. M., Fitzgerald, T. L., Bertrand, F. E., & Sigounas, G. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25196 · Cited by 158
Understanding cell‐cell communication and signaling in the colorectal cancer microenvironment
AlMusawi, S., Ahmed, M., & Nateri, A. S. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.308 · Cited by 151
A phase II study of RO4929097 in metastatic colorectal cancer
Strosberg, J. R., Yeatman, T., Weber, J., Coppola, D., Schell, M. J., Han, G., Almhanna, K., Kim, R., Valone, T., Jump, H., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.056 · Cited by 146
The role of Hes genes in intestinal development, homeostasis and tumor formation
Ueo, T., Imayoshi, I., Kobayashi, T., Ohtsuka, T., Seno, H., Nakase, H., Chiba, T., & Kageyama, R. (2012) · Development · doi:10.1242/dev.069070 · Cited by 146
Singh, M. P., Rai, S., Pandey, A., Singh, N. K., & Srivastava, S. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2019.10.013 · Cited by 146
cis-Inhibition of Notch by Endogenous Delta Biases the Outcome of Lateral Inhibition
Miller, A. C., Lyons, E. L., & Herman, T. G. (2009) · Current Biology · doi:10.1016/j.cub.2009.06.042 · Cited by 145
Islam, F., Gopalan, V., Smith, R. A., & Lam, A. K.-Y. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.018 · Cited by 145
Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer
Naccarati, A., Polakova, V., Pardini, B., Vodickova, L., Hemminki, K., Kumar, R., & Vodicka, P. (2012) · Mutagenesis · doi:10.1093/mutage/ger067 · Cited by 143
Epsin-Dependent Ligand Endocytosis Activates Notch by Force
Langridge, P. D., & Struhl, G. (2017) · Cell · doi:10.1016/j.cell.2017.10.048 · Cited by 143
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches
Cleophas, M. C. P., Joosten, L. A. B., Stamp, L. K., Dalbeth, N., Woodward, O. M., & Merriman, T. R. (2017) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s105854 · Cited by 142
Tarantino, I., Warschkow, R., Worni, M., Cerny, T., Ulrich, A. B., Schmied, B. M., & Güller, U. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000860 · Cited by 140
Fringe proteins modulate Notch-ligand cis and trans interactions to specify signaling states
LeBon, L., Lee, T. V., Sprinzak, D., Jafar-Nejad, H., & Elowitz, M. B. (2014) · eLife · doi:10.7554/elife.02950 · Cited by 139
Dzobo, K., Senthebane, D. A., Ganz, C., Thomford, N. E., Wonkam, A., & Dandara, C. (2020) · Cells · doi:10.3390/cells9081896 · Cited by 127
Nakano, M., Kikushige, Y., Miyawaki, K., Kunisaki, Y., Mizuno, S., Takenaka, K., Tamura, S., Okumura, Y., Ito, M., Ariyama, H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0480-0 · Cited by 125
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia
Gil Vazquez, E., Nasreddin, N., Valbuena, G. N., Mulholland, E. J., Belnoue-Davis, H. L., Eggington, H. R., Schenck, R. O., Wouters, V. M., Wirapati, P., Gilroy, K., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.07.008 · Cited by 125
Cis-activation in the Notch signaling pathway
Nandagopal, N., Santat, L. A., & Elowitz, M. B. (2019) · eLife · doi:10.7554/elife.37880 · Cited by 123
Functional Diversity among Notch1, Notch2, and Notch3 Receptors
Shimizu, K., Chiba, S., Saito, T., Kumano, K., Hamada, Y., & Hirai, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6528 · Cited by 121
Fischer, M., Yen, W.-C., Kapoun, A. M., Wang, M., O'Young, G., Lewicki, J., Gurney, A., & Hoey, T. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2817 · Cited by 120
Leedham, S. J., Brittan, M., McDonald, S. A. C., & Wright, N. A. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00333.x · Cited by 118
Le, N. H., Franken, P., & Fodde, R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604401 · Cited by 116
Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells
Colak, S., Zimberlin, C. D., Fessler, E., Hogdal, L., Prasetyanti, P. R., Grandela, C. M., Letai, A., & Medema, J. P. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.37 · Cited by 114
Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity
Sung, P.-J., Rama, N., Imbach, J., Fiore, S., Ducarouge, B., Neves, D., Chen, H.-W., Bernard, D., Yang, P.-C., Bernet, A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2952 · Cited by 103
Self-citationmiR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1
Liu, H., Yin, Y., Hu, Y., Feng, Y., Bian, Z., Yao, S., Li, M., You, Q., & Huang, Z. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.04.011 · Cited by 101
Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer
Chu, D., Zhang, Z., Zhou, Y., Wang, W., Li, Y., Zhang, H., Dong, G., Zhao, Q., & Ji, G. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq776 · Cited by 100
Notch3 signalling promotes tumour growth in colorectal cancer
Serafin, V., Persano, L., Moserle, L., Esposito, G., Ghisi, M., Curtarello, M., Bonanno, L., Masiero, M., Ribatti, D., Stürzl, M., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2895 · Cited by 98
Sun, L., Ke, J., He, Z., Chen, Z., Huang, Q., Ai, W., Wang, G., Wei, Y., Zou, X., Zhang, S., et al. (2017) · Journal of Cancer · doi:10.7150/jca.19142 · Cited by 91
Ebrahimi, N., Afshinpour, M., Fakhr, S. S., Kalkhoran, P. G., Shadman-Manesh, V., Adelian, S., Beiranvand, S., Rezaei-Tazangi, F., Khorram, R., Hamblin, M. R., et al. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.103920 · Cited by 91
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
Xiang, D., Shigdar, S., Bean, A. G., Bruce, M., Yang, W., Mathesh, M., Wang, T., Yin, W., Tran, P. H.-L., Shamaileh, H. A., et al. (2017) · Theranostics · doi:10.7150/thno.20168 · Cited by 91
Jin, Y., Wang, M., Hu, H., Huang, Q., Chen, Y., & Wang, G. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.151 · Cited by 91
Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin
Wang, Q., Chen, X., Jiang, Y., Liu, S., Liu, H., Sun, X., Zhang, H., Liu, Z., Tao, Y., Li, C., et al. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz032 · Cited by 90
γ-Secretase Inhibitors Enhance Taxane-Induced Mitotic Arrest and Apoptosis in Colon Cancer Cells
Akiyoshi, T., Nakamura, M., Yanai, K., Nagai, S., Wada, J., Koga, K., Nakashima, H., Sato, N., Tanaka, M., & Katano, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.008 · Cited by 89
Francescangeli, F., Contavalli, P., De Angelis, M. L., Careccia, S., Signore, M., Haas, T. L., Salaris, F., Baiocchi, M., Boe, A., Giuliani, A., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1505-4 · Cited by 88
Pannequin, J., Bonnans, C., Delaunay, N., Ryan, J. L., Bourgaux, J., Joubert, D., & Hollande, F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2409 · Cited by 87
Self-citationLgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer
Leng, Z., Xia, Q., Chen, J., Li, Y., Xu, J., Zhao, E., Zheng, H., Ai, W., & Dong, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488743 · Cited by 87
Overview: Cellular plasticity, cancer stem cells and metastasis
ElShamy, W. M., & Duhé, R. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.020 · Cited by 85
Liu, Z., Brunskill, E., Varnum-Finney, B., Zhang, C., Zhang, A., Jay, P. Y., Bernstein, I., Morimoto, M., & Kopan, R. (2015) · Development · doi:10.1242/dev.125492 · Cited by 85
STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway
Jin, L., Vu, T., Yuan, G., & Datta, P. K. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0286 · Cited by 85
Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance
Das, P. K., Pillai, S., Rakib, M. A., Khanam, J. A., Gopalan, V., Lam, A. K.-Y., & Islam, F. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09942-y · Cited by 81
Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase
Moran, R. G. (1989) · Cancer · doi:10.1002/1097-0142(19890315)63:6+<1008::aid-cncr2820631303>3.0.co;2-z · Cited by 77
Cancer Stem Cell Epigenetics And Chemoresistance
Crea, F., Danesi, R., & Farrar, W. L. (2009) · Epigenomics · doi:10.2217/epi.09.4 · Cited by 74
Competition in Notch Signaling with Cis Enriches Cell Fate Decisions
Formosa-Jordan, P., & Ibañes, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095744 · Cited by 72
Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells
Sarkar, S., Mirzaei, R., Zemp, F. J., Wei, W., Senger, D. L., Robbins, S. M., & Yong, V. W. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2171 · Cited by 70
Apoptotic Death of Cancer Stem Cells for Cancer Therapy
He, Y., Zhou, F., Shen, Y., Liao, D., & Cao, D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058335 · Cited by 69
ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status
Feng, H., Liu, Y., Bian, X., Zhou, F., & Liu, Y. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.363 · Cited by 68
Liu, Z., Xu, H., Weng, S., Ren, Y., & Han, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828330 · Cited by 67
Identification of novel Notch target genes in T cell leukaemia
Chadwick, N., Zeef, L. A. H., Portillo, V., Fennessy, C., Warrander, F., Hoyle, S., & Buckle, A. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-35 · Cited by 66
Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer
Sacchetti, A., Teeuwssen, M., Verhagen, M., Joosten, R., Xu, T., Stabile, R., van der Steen, B., Watson, M. M., Gusinac, A., Kim, W. K., et al. (2021) · eLife · doi:10.7554/elife.61461 · Cited by 66
Puca, F., Colamaio, M., Federico, A., Gemei, M., Tosti, N., Bastos, A. U., Vecchio, L. D., Pece, S., Battista, S., & Fusco, A. (2014) · Oncotarget · doi:10.18632/oncotarget.1914 · Cited by 65
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity
Biswas, A., & De, S. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00575.2020 · Cited by 65
LIU, D., Sun, J., Zhu, J., Zhou, H., Zhang, X., & Zhang, Y. (2014) · Oncology Letters · doi:10.3892/ol.2014.1907 · Cited by 64
Srinivasan, T., Walters, J. N., Bu, P., Than, E. B., Tung, K., Chen, K., Panarelli, N. C., Milsom, J., Augenlicht, L. H., Lipkin, S. M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3198 · Cited by 63
Targeting cancer stem‐like cells in glioblastoma and colorectal cancer through metabolic pathways
Kahlert, U. D., Mooney, S. M., Natsumeda, M., Steiger, H. ‐., & Maciaczyk, J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30259 · Cited by 62
HUANG, R., WANG, G., SONG, Y., TANG, Q., YOU, Q., LIU, Z., CHEN, Y., ZHANG, Q., LI, J., MUHAMMAND, S., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3694 · Cited by 61
Understanding the Cause and Consequence of Tumor Heterogeneity
Khatib, S., Pomyen, Y., Dang, H., & Wang, X. W. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.010 · Cited by 60
Li, D., Zhao, C., Ding, H., Wu, Q., Ren, T., Wang, J., Chen, C., & Zhao, Q. (2018) · Cell Proliferation · doi:10.1111/cpr.12480 · Cited by 60
Vishnubalaji, R., Manikandan, M., Fahad, M., Hamam, R., Alfayez, M. A., Kassem, M. S., Aldahmash, A. M., & Alajez, N. M. (2018) · Oncotarget · doi:10.18632/oncotarget.24420 · Cited by 59
Dependence receptors: new targets for cancer therapy
Brisset, M., Grandin, M., Bernet, A., Mehlen, P., & Hollande, F. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114495 · Cited by 59
Self-citationYING, J., Tsujii, M., Kondo, J., Hayashi, Y., Kato, M., Akasaka, T., INOUE, T., Shiraishi, E., INOUE, T., Hiyama, S., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2851 · Cited by 59
NOTCH3 Signaling Regulates MUSASHI-1 Expression in Metastatic Colorectal Cancer Cells
Pastò, A., Serafin, V., Pilotto, G., Lago, C., Bellio, C., Trusolino, L., Bertotti, A., Hoey, T. C., Plateroti, M., Esposito, G., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2022 · Cited by 58
Serrated and Non-Serrated Precursor Lesions of Colorectal Cancer
Langner, C. (2014) · Digestive Diseases · doi:10.1159/000366032 · Cited by 57
Zine, A., & de Ribaupierre, F. (2002) · Hearing Research · doi:10.1016/s0378-5955(02)00449-5 · Cited by 57
γH2AX Assay as DNA Damage Biomarker for Human Population Studies: Defining Experimental Conditions
Sánchez-Flores, M., Pásaro, E., Bonassi, S., Laffon, B., & Valdiglesias, V. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv011 · Cited by 56
Distinct roles of EGF repeats for the Notch signaling system
Sakamoto, K., Chao, W. S., Katsube, K., & Yamaguchi, A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.09.016 · Cited by 56
Solier, S., Zhang, Y., Ballestrero, A., Pommier, Y. G., & Zoppoli, G. M. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912800190901 · Cited by 56
Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma
Eberl, M., Mangelberger, D., Swanson, J. B., Verhaegen, M. E., Harms, P. W., Frohm, M. L., Dlugosz, A. A., & Wong, S. Y. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.12.015 · Cited by 53
Guilmeau, S., Flández, M., Mariadason, J. M., & Augenlicht, L. H. (2009) · Oncogene · doi:10.1038/onc.2009.393 · Cited by 52
Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer
Song, R., Gu, D., Zhang, L., Zhang, X., Yu, B., Liu, B., & Xie, J. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22883 · Cited by 51
Zangiacomi, V., Urakami, K., Maruyama, K., Yamaguchi, K., & Kusuhara, M. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.23 · Cited by 49
Radiation-induced DNA damage response and resistance in colorectal cancer stem-like cells
Anuja, K., Chowdhury, A. R., Saha, A., Roy, S., Rath, A. K., Kar, M., & Banerjee, B. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1580401 · Cited by 48
Notch2 Expression Is Decreased in Colorectal Cancer and Related to Tumor Differentiation Status
Chu, D., Zheng, J., Wang, W., Zhao, Q., Li, Y., Li, J., Xie, H., Zhang, H., Dong, G., Xu, C., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0655-6 · Cited by 48
Wang, R., Ye, X., Bhattacharya, R., Boulbés, D. R., Fan, F., Xia, L., & Ellis, L. M. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0168 · Cited by 47
Kim, J. H., Seo, M.-K., Lee, J. A., Yoo, S., Oh, H. J., Kang, H., Cho, N., Bae, J. M., Kang, G. H., & Kim, S. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003414 · Cited by 46
Peng, Y., Li, Z., Yang, P., Newton, I. P., Ren, H., Zhang, L., Wu, H., & Li, Z. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.074 · Cited by 45
Irshad, S., Bansal, M., Guarnieri, P., Belnoue-Davis, H. L., Zen, A. A. H., Baran, B., Pinna, C. M. A., Rahman, H., Biswas, S., Bardella, C., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4891 · Cited by 45
Kaiser, A. M., Kang, J., Chan, L. S., & Beart, R. W. (2006) · Colorectal Disease · doi:10.1111/j.1463-1318.2006.01017.x · Cited by 44
Zhou, Y., Lu, X., Chen, H., Wang, X., Cheng, W., Zhang, Q., Chen, J.-N., Wang, X., Jin, J.-Z., Yan, F., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.001 · Cited by 42
Genomic landscape of colorectal carcinogenesis
Kim, J. C., & Bodmer, W. F. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03888-w · Cited by 42
Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy
Kaur, J., & Bhattacharyya, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.756888 · Cited by 41
Dosch, J., Ziemke, E., Wan, S., Luker, K., Welling, T., Hardiman, K., Fearon, E., Thomas, S., Flynn, M., Rios-Doria, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17780 · Cited by 40
Butler, S. J., Richardson, L. M., Farias, N., Morrison, J. A., & Coomber, B. L. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.176 · Cited by 40
Targeting Notch Signaling in Colorectal Cancer
Suman, S., Das, T. P., Ankem, M. K., & Damodaran, C. (2014) · Current Colorectal Cancer Reports · doi:10.1007/s11888-014-0252-3 · Cited by 39
Differential regulation of Hes/Hey genes during inner ear development
Petrovic, J., Gálvez, H., Neves, J., Abelló, G., & Giráldez, F. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22243 · Cited by 37
Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer
Schmidt, E. M., Lamprecht, S., Blaj, C., Schaaf, C. P., Krebs, S., Blum, H., Hermeking, H., Jung, A., Kirchner, T., & Horst, D. A. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171455 · Cited by 36
Arcaroli, J. J., Powell, R. W., Varella‐Garcia, M., McManus, M. C., Tan, A. C., Quackenbush, K. S., Pitts, T. M., Gao, D., Spreafico, A., Dasari, A. N., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.03.004 · Cited by 36
Research works printed but not linked: 1
- Huang, Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor, Mol. Med. Rep., 12, 2417, 10.3892/mmr.2015.3694 · DOI · Paper page
Cited by
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“The Notch signaling pathway plays a significant role in CSC self-renewal and cell fate decisions, and dysregulated Notch signaling contributes to CRC progression, chemore-sistance, and CSC heterogeneity [196].”
The Impact of Cancer Stem Cells in Colorectal Cancer
Radu, P., Zurzu, M., Tigora, A., Paic, V., Bratucu, M., Garofil, D., Surlin, V., Munteanu, A. C., Coman, I. S., Popa, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084140 · Cited by 30
Sun, J., Chen, Y., Xu, Z., Wang, W. W., & Li, P. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06282-z · Cited by 30
Parry, R. A., Mir, I. A., Bhat, B. A., Hussain, M. U., Ashraf, S., Zaman, G. S., Bashir, N., Vats, S., & Ganie, S. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-89714-6 · Cited by 10
A dynamic molecular landscape in colorectal cancer progression at single-cell resolution
Sheng, J., Li, N., Li, S., Ye, Y., Liao, Y., Zhang, Y., Chen, H., Tu, M., Zhong, G., Xiong, C., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06785-9 · Cited by 10
Metadata
- Authors
- Brisset, M., Mehlen, P., Meurette, O., & Hollande, F.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- The University of Melbourne (AU)
- Corresponding author
- Hollande, Frédéric
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2023-10-04
- Volume
- 11
- Pages
- 1231416-1231416
- ISSN
- 2296-634X (ISSN-L)
- PMC
- PMC10582728
- OpenAlex
- W4387335582
- Cited by
- 20
- References
- 241
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 1
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- Notch signaling, Notch receptor, Notch ligands, colorectal cancer, cancer stem cells, tumor heterogeneity, chemoresistance, self-renewal, stemness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.